Form 8-K - Current report:
SEC Accession No. 0001654954-22-001378
Filing Date
2022-02-10
Accepted
2022-02-10 08:00:47
Documents
15
Period of Report
2022-02-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K endra.htm   iXBRL 8-K 26198
2 PRESS RELEASE endra_ex991.htm EX-99.1 15642
  Complete submission text file 0001654954-22-001378.txt   169553

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndra-20220209.xsd EX-101.SCH 5837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20220209_lab.xml EX-101.LAB 15305
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20220209_cal.xml EX-101.CAL 900
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20220209_pre.xml EX-101.PRE 9742
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20220209_def.xml EX-101.DEF 2105
9 EXTRACTED XBRL INSTANCE DOCUMENT endra_htm.xml XML 3716
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 22609632
SIC: 3845 Electromedical & Electrotherapeutic Apparatus